nicotine has been researched along with Depression in 193 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (3.63) | 18.7374 |
| 1990's | 18 (9.33) | 18.2507 |
| 2000's | 70 (36.27) | 29.6817 |
| 2010's | 76 (39.38) | 24.3611 |
| 2020's | 22 (11.40) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, R; Bhyrapuneni, G; Bogaraju, N; Jasti, V; Mekala, VR; Mohammed, AR; Muddana, N; Nirogi, R; Palacharla, RC; Ravella, SR; Shinde, AK; Subramanian, R; Thentu, JB | 1 |
| Fryxell, KJ; Hudson, AD; Locklear, LL; Murphy, RL; Niaz, MH; Walton, RL | 1 |
| Bhide, PG; Biederman, J; Levenson, CW; Salazar, VC; Zafonte, R; Zhang, L | 1 |
| D'Souza, MS; Emerson, N; Ho, SP; Huan, CY; Kuo, H; Rorabaugh, BR; Rose-Malkamaki, MJ; Seeley, SL; Tsai, YC | 1 |
| Fluyau, D; Jain, A; Kailasam, VK; Mitra, P; Pierre, CG | 1 |
| Andreasen, JT | 1 |
| Cropsey, KL; Gamble, KL; Hawes, ES; Mildrum Chana, S; Palenski, PE; Thomas, SJ; Wolford-Clevenger, C | 1 |
| 'Cleirigh, CO; Bamford, L; Cachay, E; Chander, G; Christopoulos, K; Crane, HM; Cropsey, K; Delaney, JAC; Drumright, LN; Eltonsy, S; Eron, JJ; Fredericksen, RJ; Hahn, AW; Haidar, L; Jacobson, JM; Ma, J; Mayer, KH; Nance, RM; Napravnik, S; Ruderman, SA; Whitney, BW; Willig, A | 1 |
| Cassidy, R; DeAtley, T; Harrison, A; Higgins, ST; Kuo, C; Tidey, JW | 1 |
| Bońka, A; Bryl, W; Hoffmann, K; Kopciuch, D; Kus, K; Michalak, M; Nowakowska, E; Paczkowska, A; Ratajczak, P; Zaprutko, T | 1 |
| Ahmadi-Soleimani, SM; Amiry, GY; Azhdari-Zarmehri, H; Beheshti, F; Haidary, M | 1 |
| Chen, B; Clendennen, SL; Harrell, MB; Smith, J; Sumbe, A; Wilkinson, AV | 1 |
| Audrain-McGovern, J; DeAtley, T; Johnson, AC; Mercincavage, M; Stone, MD; Strasser, AA | 1 |
| Badawy, AA; Bano, S; Hamid, SB; Sajid, F; Sharif, H | 1 |
| Arora, S; Loukas, A; Nathan Marti, C | 1 |
| Hoeng, J; Koshibu, K; Peitsch, MC; Veljkovic, E; Xia, W | 1 |
| Davis, DR; Desarno, MJ; Diaz, V; Gaalema, DE; Heil, SH; Higgins, ST; Hughes, JR; Sigmon, SC; Stitzer, ML; Tidey, JW | 1 |
| Green, M; Hudson, R; Jobson, CEL; Jung, T; Laviolette, SR; Renard, J; Rushlow, W; Wright, DJ | 1 |
| Ahmad, SM; Hamid, A; Lutfy, K; Marquez, P; Nega, S | 1 |
| Fukunaga, K; Inagaki, R; Moriguchi, S; Sakagami, H; Shibata, M; Yi, L | 1 |
| Burroughs, D; LeSage, MG; Pentel, PR; Rezvani, AH; Saykao, A; Smethells, JR | 1 |
| Gilbert, DG; Newcomer, JW; Pergadia, ML | 1 |
| Fujigaki, H; Fujigaki, S; Hasegawa, M; Hirakawa, M; Hoshi, M; Kosuge, A; Kubota, H; Kunisawa, K; Kurahashi, H; Mori, Y; Mouri, A; Murakami, R; Nabeshima, T; Nakano, T; Niijima, M; Saito, K; Yamamoto, Y | 1 |
| Gorfinkel, L; Hasin, D; Keyes, KM; Miech, R | 1 |
| Dai, J; Nie, D; Qiao, Z; Wang, L; Wang, Z; Xu, W; Zhang, D; Zhang, M; Zhao, X; Zhu, Z | 1 |
| Gandelman, JA; Newhouse, P; Taylor, WD | 1 |
| Chellian, R; Mohamed, Z; Pandy, V | 1 |
| Shang, X; Xiao, X; Zhai, B; Zhang, H; Zhang, T | 1 |
| Biala, G; Budzynska, B; Kruk-Slomka, M; Michalak, A; Pekala, K | 1 |
| Laikowski, MM; Moura, S; Reisdorfer, F | 1 |
| Cao, Y; Dai, J; He, G; Qiao, Z; Wang, L; Wang, Z; Wu, J; Xu, W; Zhang, D; Zhang, M; Zhao, X | 1 |
| Cryan, JF; Jacobson, LH; Li, X; Slattery, DA; Vlachou, S | 1 |
| Al-Mrayat, YD; Khara, M; Okoli, CTC; Shelton, CI | 1 |
| D'Souza, MS; Norman, H; Rorabaugh, BR; Seeley, SL; Sprague, L | 1 |
| Jobson, CLM; Laviolette, SR; Pereira, B; Renard, J; Rosen, LG; Rushlow, W; Szkudlarek, H; Wright, DJ | 1 |
| Airagnes, G; Goldberg, M; Gomajee, R; Le Faou, AL; Lemogne, C; Lequy, E; Limosin, F; Melchior, M; Wiernik, E; Zins, M | 1 |
| Lopresti, AL | 1 |
| Gard, AM; Schmitz, LL; Ware, EB | 1 |
| Hitsman, B; Leone, FT; Schnoll, RA | 1 |
| Brown, VL; Cinciripini, PM; Engelmann, JM; Karam-Hage, M; Lam, C; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW | 1 |
| Anderson, G; Maes, M | 1 |
| Newhouse, PA; Taylor, WD; Zurkovsky, L | 1 |
| Chen, H; Han, W; Jiang, Q; Palmer, AA; Solberg-Woods, LC; Wang, B; Wang, T | 1 |
| Abramovitch, A; Pizzagalli, DA; Reuman, L; Wilhelm, S | 1 |
| Rahman, S; Roni, MA | 1 |
| Biała, G; Budzyńska, B; Kruk-Słomka, M; Michalak, A; Polak, P | 1 |
| D'Souza, MS; Der-Avakian, A; Heath, AC; Madden, PAF; Markou, A; Pergadia, ML; Pizzagalli, DA; Shiffman, S | 1 |
| Bloom, EL; Brown, RA; Hayes, SC; Minami, H; Reed, KM | 1 |
| Eakin, MN; Hilliard, ME; Hovell, MF; Rand, CS; Riekert, KA; Welkom, JS | 1 |
| Chopde, CT; Kotagale, NR; Taksande, BG; Umekar, MJ | 1 |
| Curran, HV; Das, RK; Freeman, TP; Hindocha, C; Lawn, W; Mokrysz, C; Morgan, CJ | 1 |
| Blazekovic, S; Gariti, P; Goelz, PM; Hitsman, B; Kaufmann, A; Leone, FT; Powers, L; Schnoll, RA; Tyndale, RF; Veluz-Wilkins, A | 1 |
| Dawe, GS; den Hollander, B; Farooq, U; Hyytiä, P; Korpi, ER; Nutt, DJ; Rajkumar, R; Vashchinkina, E | 1 |
| Fatima, S; Ganji, S; Karimian, M; Motaghinejad, M | 1 |
| Biala, G; Budzynska, B; Kruk-Slomka, M; Skalicka-Wozniak, K; Wydrzynska-Kuzma, M | 1 |
| Audrain-McGovern, JE; Blazekovic, S; Hitsman, B; Leone, FT; Schnoll, RA; Veluz-Wilkins, A; Wileyto, EP | 1 |
| Hayase, T | 5 |
| Cunningham, JA; Kushnir, V; Leatherdale, ST; Selby, P; Sproule, BA; Tyndale, RF; Zawertailo, L | 1 |
| al'Absi, M; Benowitz, NL; Cassidy, R; Denlinger, RL; Dermody, SS; Donny, EC; Drobes, DJ; Hatsukami, DK; Koopmeiners, JS; Lemieux, A; Nardone, N; Pacek, LR; Tidey, JW; Vandrey, R | 1 |
| Connelly, KL; Gould, TJ; Holliday, ED; Kutlu, MG; Nucero, P; Oliver, C; Unterwald, EM | 1 |
| Bagosi, Z; Balangó, B; Bokor, P; Buzás, A; Csabafi, K; Jászberényi, M; Palotai, M; Pintér, D; Simon, B; Szabó, G | 1 |
| Cador, M; Caillé, S; Rubino, T; Simonnet, A; Zamberletti, E | 1 |
| Kim, NC; Oh, CU | 1 |
| Gilbert, DG; Rabinovich, NE; Zuo, Y | 1 |
| Epstein, A; King, A; Munisamy, G; Walsh, Z | 1 |
| Drucker-Colín, R; Mineur, YS; Picciotto, MR; Túnez, I; Vidaltamayo, R; Vieyra-Reyes, P | 1 |
| Cooney, JL; Cooney, NL; McKee, SA; O'Malley, SS; Toll, BA | 1 |
| Hébert, R | 2 |
| Carlson, JM; Froeliger, B; Gilbert, DG; Rabinovich, NE; Riise, H; Sugai, C | 2 |
| Semba, J; Wakuta, M | 1 |
| Getachew, B; Hauser, SR; Overstreet, DH; Rezvani, AH; Tizabi, Y | 1 |
| Allan, R; Atkinson, J; Fleming, M; Martin, CR | 1 |
| Garvey, AJ; Kinnunen, T; Korhonen, T | 1 |
| Alcantara, LF; Bolaños-Guzmán, CA; Iñiguez, SD; Maffeo, ML; Manojlovic, Z; Parise, EM; Schuh, B; Warren, BL | 1 |
| Clark, MM; Croghan, IT; Decker, PA; Ebbert, JO; Hathaway, J; Hurt, RD; Lewis, BA; Marcus, BH; Patten, CA; Ussher, M; Vickers, KS | 1 |
| Rigotti, NA; Thorndike, AN | 1 |
| Getachew, B; Hauser, SR; Madani, R; Manaye, KF; Sharma, Y; Tizabi, Y; Tyler, KY | 1 |
| Batra, A; Buchkremer, G; Collins, SE; Eck, S; Schröter, M; Torchalla, I | 1 |
| Baker, TB; Bolt, DM; Japuntich, SJ; Piper, ME; Schlam, TR | 1 |
| Bleich, S; Clepce, M; Frieling, H; Gossler, A; Hillemacher, T; Killisch, N; Klafki, HW; Kornhuber, J; Lenz, B; Schaller, G; Thuerauf, N; Winterer, G | 1 |
| Glass, M; Kuzla, N; Langer, C; Leone, F; Martinez, E; Miyamoto, C; Ridge, JA; Schnoll, RA; Tatum, KL; Weber, DM; Wileyto, EP | 1 |
| Filip, M; McCreary, AC; Wydra, K; Zaniewska, M | 1 |
| Gracia, MC | 1 |
| Blendy, JA; Castellano, LM; Turner, JR | 1 |
| Der-Avakian, A; Markou, A | 1 |
| Ericson, M; Norrsjö, G; Svensson, AI | 1 |
| Hooten, WM; Mantilla, CB; Shi, Y; Warner, DO; Weingarten, TN | 1 |
| Arnold, S; Gandhi, D; Joshi, A; Khanna, N; Sadaphal, S; Stewart, D | 1 |
| Busch, AM; Kahler, CW; Leventhal, AM; Spillane, NS | 1 |
| Andreasen, JT; Bate, S; Christiansen, S; Henningsen, K; Wiborg, O | 1 |
| Banerjee, D; Finn, MG; Froestl, W; Guery, S; Kaupmann, K; Markou, A; Paterson, NE; Vlachou, S | 1 |
| Domino, EF; Jutkiewicz, EM; Ohmura, Y | 1 |
| Hipwell, AE; Loeber, R; van der Molen, E; Vermeiren, R | 1 |
| Abreu-Villaça, Y; Filgueiras, CC; Lima, CS; Manhães, AC; Nunes-Freitas, AL; Ribeiro-Carvalho, A | 1 |
| Edwards, AC; Kendler, KS | 1 |
| Iezhitsa, IN; Kharitonova, MV; Kravchenko, MS; Spasov, AA | 1 |
| Ball, D; O'Gara, C; Spirling, LI; Stapleton, JA; Sutherland, G | 1 |
| Blazer, DG; Orr, CA; Orr, ST | 1 |
| Dorner, TE; Groman, E; Tröstl, A; Womastek, I | 1 |
| El-Shamy, KA; Khadrawy, YA; Mohamed, SI | 1 |
| Colder, CR; Eiden, RD; Gray, TR; Homish, GG; Huestis, MA; Leonard, KE; Schuetze, P | 1 |
| Furberg, CD; Glenmullen, J; Maltsberger, JT; Moore, TJ; Singh, S | 1 |
| al'Absi, M; Nakajima, M | 1 |
| Murphy, RS; Parrott, AC | 1 |
| Contet, C; Markou, A; Roberts, AJ; Semenova, S | 1 |
| Ilivitsky, V; Knott, V; Shah, D; Thompson, A | 1 |
| Sanberg, PR; Shytle, RD; Vindrola-Padros, C | 1 |
| Calapai, G; Calzavara, E; Caputi, AP; Mannucci, C; Navarra, M | 1 |
| Al'absi, M; Allen, AM; Allen, SS; Hatsukami, D; Kotlyar, M; Lunos, S | 1 |
| Lukas, RJ; Newman, MB; Sanberg, PR; Sheehan, DV; Shytle, RD; Silver, AA | 1 |
| Brunzell, DH; Caldarone, BJ; Picciotto, MR | 1 |
| Fortmann, SP; Killen, JD; Kraemer, HC; Varady, A | 1 |
| Marr, L; Ressman, K; Sobrian, SK | 1 |
| Parrott, AC | 2 |
| Baile, WF; Blalock, JA; Carter, BL; Cinciripini, LG; Cinciripini, PM; Fouladi, RT; Wetter, DW | 1 |
| Allen, SS; Christianson, D; Hatsukami, DK | 1 |
| Ahluwalia, JS; Catley, D; Nazir, N; Resnicow, K | 1 |
| Baker, TB; Fiore, MC; Jamerson, B; Johnston, JA; Jorenby, DE; Leischow, SJ; Nides, MA; Rennard, SI; Smith, SS | 1 |
| Corwin, EJ; Klein, LC | 1 |
| Glover, ED; Glover, PN; Payne, TJ | 1 |
| Maeda, J; Semba, J; Suhara, T; Wakuta, M | 1 |
| Audrain-McGovern, J; Jepson, C; Kaufmann, V; Kucharski, S; Lerman, C; Patterson, F; Rukstalis, M | 1 |
| Achour, N; Aouina, H; Bouacha, H; Fakhfakh, R; Gharbi, L; Hsairi, M | 1 |
| Bonilla-Jaime, H; Vázquez-Palacios, G; Velázquez-Moctezuma, J | 1 |
| Asgaard, G; Botros, N; Gilbert, D; Huggenvik, J; McClernon, J; Plath, L; Rabinovich, N; Sugai, C; Zuo, Y | 1 |
| Ehlers, CL; Slawecki, CJ; Thorsell, A | 1 |
| Levin, TT; Paperwalla, KN; Saravay, SM; Weiner, J | 1 |
| Eisendrath, SJ; Hall, SM; Humfleet, GL; Meisner, MR; Prochaska, JJ; Redding, CA; Rosen, AB; Rossi, JS; Tsoh, JY | 1 |
| Allen, SS; Bade, T; Center, B; Hatsukami, DK | 1 |
| Mehringer, AM; Ninowski, R; Pomerleau, CS; Pomerleau, OF; Sen, A; Snedecor, SM | 1 |
| Besheer, J; Bevins, RA | 1 |
| Ehlers, CL; El Khoury, A; Mathé, AA; Slawecki, CJ; Thorsell, AK | 1 |
| Bertrand, D | 1 |
| Ceballos, NA; Lawton-Craddock, A; Nixond, SJ; Tivis, R | 1 |
| Adam, EK | 1 |
| Czubak, A; Florek, E; Jodynis-Liebert, J; Kus, K; Nowakowska, E | 1 |
| Bellomo, M; Calapai, G; Caputi, AP; Mannucci, C; Tedesco, M | 1 |
| Fryxell, KJ; Polesskaya, OO; Smith, RF | 1 |
| Markou, A | 1 |
| Kneller, S | 1 |
| Hiott, FB; Levin, ED; McClernon, FJ; Rose, JE; Westman, EC | 1 |
| Bergström, E; de Vries, H; Panday, S; Reddy, SP; Ruiter, RA | 1 |
| Creeden, CL; George, TP; Jatlow, PI; Sacco, KA; Vessicchio, JC; Weinberger, AH | 1 |
| Pavarin, RM | 1 |
| Calderón-Ezquerro, C; Drucker-Colín, R; Moreno-Coutiño, A | 1 |
| Lechi, A; Lugoboni, F; Mezzelani, P; Pajusco, B; Quaglio, G | 1 |
| Dillon, A; Gilbert, DG; Huber, J; Rabinovich, NE; Riise, H; Sugai, C | 1 |
| al'Absi, M; Cohen, LM; Morrell, HE | 1 |
| Markou, A; Paterson, NE; Semenova, S | 1 |
| Christie, JE; Dick, H; Fink, G; Levy, G; Rosie, R; Sheward, WJ; Watts, AG; Whalley, LJ | 1 |
| Janowsky, DS; Nurnberger, JI; Overstreet, DH | 1 |
| Breslau, N | 1 |
| Cogswell, BE | 1 |
| Hall, SM; Muñoz, RF; Reus, VI; Sees, KL | 1 |
| Downey, K; Lumley, MA; Pomerleau, OF; Stettner, L; Wehmer, F | 1 |
| Cooper, TB; Covey, LS; Dalack, GW; Fleiss, J; Glassman, AH; Rivelli, SK; Stetner, F | 1 |
| Baker, TB; Fiore, MC; Jorenby, DE; Kenford, SL; Smith, SS; Wetter, DW | 1 |
| Breslau, N; Peterson, EL | 1 |
| Davis, L; Fortmann, SP; Killen, JD; Kraemer, HC; Newman, B; Varady, AN | 1 |
| Brown, LS; Lin, MM; Meyer, TJ | 1 |
| Croghan, IT; Dale, LC; Glover, ED; Glover, PN; Hurt, RD; Johnston, JA; Khayrallah, MA; Offord, KP; Sachs, DP; Schroeder, DR; Sullivan, CR; Sullivan, PM | 1 |
| Audrain, J; Bowman, ED; Boyd, NR; Caporaso, N; Lerman, C; Main, D; Shields, PG | 1 |
| Haydel, KF; Killen, JD; Robinson, TN; Rojas, NL | 1 |
| Clark, E; Janowsky, DS; Kling, MA; Louis, VA; Overstreet, DH; Rezvani, AH; Tizabi, Y | 1 |
| Crauthers, DM; Gilbert, DG; Jensen, RA; McClernon, FJ; Mooney, DK | 1 |
| Lagrue, G | 1 |
| Overstreet, DH; Rezvani1, AH; Russell, LT; Tizabi, Y; Tyler, KY | 1 |
| Balfour, DJ; Ridley, DL | 1 |
| Branchek, TA; Calligaro, DO; Czachura, JF; Dreshfield-Ahmad, LJ; Evans, DC; Hemrick-Luecke, SK; Kallman, MJ; Kendrick, WT; Leander, JD; Nelson, DL; Overshiner, CD; Rasmussen, K; Wainscott, DB; Wolff, MC; Wong, DT; Xu, YC; Zgombick, JM | 1 |
| Baird, A; Quattrocki, E; Yurgelun-Todd, D | 1 |
| Fortmann, SP; Hayward, C; Killen, JD; Rothman, M; Schatzberg, AF; Strausberg, L; Sussman, L; Varady, A | 1 |
| Brodkin, JD; Ferguson, SM; Lloyd, GK; Menzaghi, F | 1 |
| Harrison, AA; Liem, YT; Markou, A | 1 |
| Carton, S | 1 |
| Drucker-Colín, R; Martínez-González, D; Mihailescu, S; Prospéro-García, O | 1 |
| Araki, H; Gomita, Y; Suemaru, K | 1 |
| Beck, RW; Fine, E; Howard, WJ; Khan, MA; O'Brien, CP; Persky, H | 1 |
| Andreski, P; Breslau, N; Kilbey, MM | 1 |
| Dilsaver, SC; Flemmer, DD | 1 |
| Belcher, M; Hajek, P; West, RJ | 1 |
| Hughes, JR | 1 |
| Croce, G; Ferrini, R; Miragoli, G | 1 |
| Harmon, JB; Lynes, TE; Marvel, JP; Smith, DH; Stump, JM; Vernier, VG | 1 |
| Benesová, O; Náhunek, K | 1 |
28 review(s) available for nicotine and Depression
| Article | Year |
|---|---|
Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysis.
Topics: Analgesics, Opioid; Anxiety; Bayes Theorem; Cocaine; Depression; Humans; Nicotine; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Substance-Related Disorders; Tobacco Use Disorder | 2022 |
[Tobacco dependence, anxiety, and depression].
Topics: Adolescent; Anxiety; Depression; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2022 |
Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression.
Topics: Affect; Animals; Brain; Brain Mapping; Cognition; Depression; Humans; Neural Pathways; Nicotine; Nicotinic Agonists | 2018 |
NAChR α4β2 Subtype and their Relation with Nicotine Addiction, Cognition, Depression and Hyperactivity Disorder.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Addictive; Cognition; Depression; Humans; Nicotine; Receptors, Nicotinic | 2019 |
The Gamma-Aminobutyric Acid B Receptor in Depression and Reward.
Topics: Allosteric Regulation; Anhedonia; Animals; Antidepressive Agents; Brain; Depression; Depressive Disorder, Major; GABA-B Receptor Agonists; Humans; Nicotine; Receptors, GABA-B; Reward; Stress, Psychological; Substance Withdrawal Syndrome | 2018 |
TRYCAT pathways link peripheral inflammation, nicotine, somatization and depression in the etiology and course of Parkinson's disease.
Topics: Animals; Depression; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation; Nicotine; Parkinson Disease; Signal Transduction; Somatoform Disorders; Tryptophan | 2014 |
Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics.
Topics: Aged; Aging; Antidepressive Agents; Brain; Cognition Disorders; Depression; Humans; Nicotine | 2013 |
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse.
Topics: Alcoholism; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamines; Animals; Behavior, Addictive; Benzodiazepines; Brain; Cannabinoids; Cocaine; Depression; Dose-Response Relationship, Drug; Gene Expression; Hallucinogens; Humans; Illicit Drugs; Narcotics; Nerve Growth Factors; Neuroimaging; Neuronal Plasticity; Nicotine; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Substance-Related Disorders; Synaptic Transmission | 2015 |
A tragic triad: coronary artery disease, nicotine addiction, and depression.
Topics: Coronary Artery Disease; Depression; Humans; Nicotine; Prevalence; Risk Factors; Smoking Cessation; Substance Withdrawal Syndrome; Syndrome; Tobacco Use Disorder; United States | 2009 |
Smoking and pain: pathophysiology and clinical implications.
Topics: Analgesics; Analgesics, Opioid; Animals; Chronic Disease; Depression; Female; Humans; Ligands; Male; Nicotine; Nicotinic Agonists; Pain; Pain, Postoperative; Receptors, Nicotinic; Risk Factors; Smoking; Smoking Cessation; Treatment Outcome | 2010 |
Translating laboratory discovery to the clinic: from nicotine and mecamylamine to Tourette's, depression, and beyond.
Topics: Animals; Basal Ganglia; Depression; Humans; Mecamylamine; Nicotine; Tourette Syndrome; Translational Research, Biomedical | 2012 |
Nicotinic acetylcholine receptors as targets for antidepressants.
Topics: Antidepressive Agents; Brain; Depression; Depressive Disorder; Drug Design; Humans; Models, Neurological; Nicotine; Nicotinic Antagonists; Receptors, Nicotinic | 2002 |
Effect of nicotine and nicotinic receptors on anxiety and depression.
Topics: Animals; Anxiety; Brain; Brain Chemistry; Depression; Humans; Neural Pathways; Neurotransmitter Agents; Nicotine; Receptors, Nicotinic; Stress, Physiological; Tobacco Use Disorder | 2002 |
Cigarette-derived nicotine is not a medicine.
Topics: Affect; Anxiety; Depression; Humans; Nicotine; Self Administration; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2003 |
Treating nicotine dependence.
Topics: Behavior Therapy; Brain; Depression; Dopamine; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2003 |
[Treatment of tobacco dependence: brief and intensive clinical intervention].
Topics: Anxiety; Bupropion; Cognitive Behavioral Therapy; Depression; Dopamine Uptake Inhibitors; Ganglionic Stimulants; Health Personnel; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2004 |
Smoking and depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depression; Humans; Nicotine; Nicotinic Agonists; Risk Factors; Smoking; Smoking Cessation | 2004 |
Novelty reward as a measure of anhedonia.
Topics: Animals; Behavior, Animal; Conditioning, Operant; Depression; Disease Models, Animal; Exploratory Behavior; Humans; Nicotine; Nicotinic Agonists; Reward; Substance Withdrawal Syndrome; Weights and Measures | 2005 |
The possible contribution of neuronal nicotinic acetylcholine receptors in depression.
Topics: Animals; Brain; Depression; Humans; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Smoking | 2005 |
Nicotine psychobiology: how chronic-dose prospective studies can illuminate some of the theoretical issues from acute-dose research.
Topics: Adolescent; Adult; Attention; Awareness; Chronic Disease; Cognitive Dissonance; Depression; Humans; Models, Psychological; Nicotine; Prospective Studies; Self Medication; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Metabotropic glutamate receptor antagonists: novel therapeutics for nicotine dependence and depression?
Topics: Animals; Depression; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Humans; Models, Biological; Nicotine; Pyridines; Receptors, Metabotropic Glutamate; Reinforcement, Psychology; Time Factors; Tobacco Use Disorder | 2007 |
Is cholinergic sensitivity a genetic marker for the affective disorders?
Topics: Animals; Cholinergic Agents; Depression; Genetic Markers; Humans; Hypothalamo-Hypophyseal System; Mood Disorders; Nicotine; Pituitary-Adrenal System; Sleep; Smoking | 1994 |
Nicotine withdrawal symptoms. A review for primary care practitioners.
Topics: Adult; Depression; Humans; Nicotine; Primary Health Care; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
Nicotine, negative affect, and depression.
Topics: Combined Modality Therapy; Depression; Humans; Neurotransmitter Agents; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1993 |
The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction?
Topics: Animals; Antidepressive Agents; Brain; Depression; Dopamine; Humans; Nicotine; Serotonin; Smoking; Tobacco Use Disorder | 2000 |
Biological aspects of the link between smoking and depression.
Topics: Affect; Brain; Cognition; Depression; Humans; Monoamine Oxidase; Neurotransmitter Agents; Nicotine; Receptors, Nicotinic; Reinforcement, Psychology; Smoking; Smoking Cessation; Smoking Prevention | 2000 |
[Psychological aspects of emotional regulation in smoking dependency].
Topics: Affect; Anxiety; Arousal; Brain Chemistry; Chronic Disease; Depression; Emotions; Humans; Models, Psychological; Motivation; Nicotine; Personality; Risk Factors; Tobacco Use Disorder | 2001 |
Neuronal nicotinic receptor and psychiatric disorders: functional and behavioral effects of nicotine.
Topics: Animals; Anxiety; Behavior, Animal; Depression; Humans; Mental Disorders; Nicotine; Receptors, Nicotinic; Schizophrenia; Substance Withdrawal Syndrome | 2002 |
34 trial(s) available for nicotine and Depression
| Article | Year |
|---|---|
Subjective experiences, contexts, and risk perceptions of very low nicotine content cigarettes and electronic cigarettes among people with depression and anxiety disorders who smoke.
Topics: Anxiety Disorders; Depression; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Products; Vaping | 2023 |
Symptoms of depression and smoking behaviors following treatment with transdermal nicotine patch.
Topics: Adolescent; Adult; Affect; Anhedonia; Depression; Humans; Linear Models; Logistic Models; Middle Aged; Nicotine; Predictive Value of Tests; Psychiatric Status Rating Scales; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome; Young Adult | 2013 |
Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.
Topics: Adolescent; Adult; Affect; Aged; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Delayed-Action Preparations; Depression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline; Young Adult | 2013 |
Association between nicotine withdrawal and reward responsiveness in humans and rats.
Topics: Adult; Animals; Conditioning, Operant; Depression; Humans; Male; Nicotine; Rats; Reward; Smoking; Substance Withdrawal Syndrome; Young Adult | 2014 |
The moderating role of experiential avoidance in the relationships between internal distress and smoking behavior during a quit attempt.
Topics: Adult; Depression; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2015 |
Longitudinal changes in smoking abstinence symptoms and alternative reinforcers predict long-term smoking cessation outcomes.
Topics: Administration, Cutaneous; Adult; Anxiety; Counseling; Craving; Depression; Female; Humans; Longitudinal Studies; Male; Nicotine; Predictive Value of Tests; Prospective Studies; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome; Young Adult | 2016 |
Effects of 6-Week Use of Reduced-Nicotine Content Cigarettes in Smokers With and Without Elevated Depressive Symptoms.
Topics: Adult; Depression; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Psychiatric Status Rating Scales; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Products; Tobacco Use Disorder; Young Adult | 2017 |
Effects of T'ai Chi on Serotonin, Nicotine Dependency, Depression, and Anger in Hospitalized Alcohol-Dependent Patients.
Topics: Adult; Alcoholism; Anger; Depression; Hospitalization; Humans; Middle Aged; Nicotine; Serotonin; Smoking; Tai Ji | 2016 |
The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation.
Topics: Administration, Cutaneous; Adult; Combined Modality Therapy; Counseling; Depression; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Personality Inventory; Smoking Cessation; Treatment Outcome | 2008 |
Effects of nicotine and depressive traits on affective priming of lateralized emotional word identification.
Topics: Administration, Cutaneous; Adolescent; Adult; Arousal; Attention; Depression; Dominance, Cerebral; Emotions; Female; Humans; Male; Nicotine; Personality Inventory; Smoking; Temperament; Verbal Learning; Visual Fields; Young Adult | 2008 |
Role of nicotine gum and pretreatment depressive symptoms in smoking cessation: twelve-month results of a randomized placebo controlled trial.
Topics: Adult; Chewing Gum; Comorbidity; Depression; Educational Status; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Marital Status; Nicotine; Placebos; Psychiatric Status Rating Scales; Smoking; Smoking Cessation; Smoking Prevention; Survival Analysis; Treatment Outcome | 2008 |
Feasibility of an exercise counseling intervention for depressed women smokers.
Topics: Adolescent; Adult; Aged; Counseling; Depression; Exercise; Feasibility Studies; Female; Humans; Middle Aged; Nicotine; Patient Compliance; Smoking; Smoking Cessation; Young Adult | 2009 |
A cluster-randomized effectiveness trial of smoking cessation modified for at-risk smoker subgroups.
Topics: Adult; Behavior Therapy; Chi-Square Distribution; Depression; Female; Health Behavior; Humans; Intention to Treat Analysis; Male; Middle Aged; Nicotine; Patient Compliance; Psychotherapy, Group; Risk-Taking; Smoking; Smoking Cessation; Social Support; Statistics, Nonparametric; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2010 |
Do smokers know what we're talking about? The construct validity of nicotine dependence questionnaire measures.
Topics: Administration, Oral; Adult; Bupropion; Chewing Gum; Combined Modality Therapy; Counseling; Depression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Motivation; Nicotine; Personality Inventory; Psychometrics; Reproducibility of Results; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
A bupropion smoking cessation clinical trial for cancer patients.
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Bupropion; Depression; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms; Nicotine; Nicotinic Agonists; Prevalence; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome | 2010 |
Time-varying smoking abstinence predicts lower depressive symptoms following smoking cessation treatment.
Topics: Adult; Depression; Female; Follow-Up Studies; Humans; Male; Multilevel Analysis; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2011 |
Neural expression of nicotine's antidepressant properties during tryptophan depletion: an EEG study in healthy volunteers at risk for depression.
Topics: Administration, Cutaneous; Affect; Alpha Rhythm; Antidepressive Agents; Brain Mapping; Cerebral Cortex; Depression; Double-Blind Method; Electroencephalography; Female; Humans; Male; Nicotine; Nicotinic Agonists; Tryptophan | 2012 |
Menstrual phase and depressive symptoms differences in physiological response to nicotine following acute smoking abstinence.
Topics: Adolescent; Adult; Cross-Over Studies; Depression; Female; Follicular Phase; Humans; Luteal Phase; Menstrual Cycle; Nicotine; Recurrence; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Young Adult | 2013 |
Do men outperform women in smoking cessation trials? Maybe, but not by much.
Topics: Administration, Cutaneous; Adult; Body Mass Index; Clinical Trials as Topic; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotine; Nicotinic Agonists; Odds Ratio; Sex Characteristics; Smoking; Smoking Cessation | 2002 |
The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy.
Topics: Adaptation, Psychological; Administration, Cutaneous; Adult; Aged; Behavior Therapy; Depression; Female; Humans; Male; Middle Aged; Nicotine; Self Efficacy; Smoking; Smoking Cessation; Smoking Prevention; Time Factors | 2003 |
Depressive symptoms and smoking cessation among inner-city African Americans using the nicotine patch.
Topics: Administration, Cutaneous; Adult; Black or African American; Depression; Female; Follow-Up Studies; Humans; Male; Nicotine; Smoking Cessation; Urban Population | 2003 |
Targeting smokers at increased risk for relapse: treating women and those with a history of depression.
Topics: Administration, Cutaneous; Bupropion; Depression; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Recurrence; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention | 2003 |
Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counseling.
Topics: Administration, Cutaneous; Administration, Intranasal; Behavior Therapy; Body Mass Index; Counseling; Depression; Female; Follow-Up Studies; Humans; Male; Nicotine; Patient Compliance; Prospective Studies; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Tobacco Use Disorder | 2003 |
Depressed smokers and stage of change: implications for treatment interventions.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Comorbidity; Depression; Female; Humans; Internal-External Control; Male; Middle Aged; Motivation; Nicotine; Personal Construct Theory; Personality Assessment; Smoking; Smoking Cessation; Treatment Outcome | 2004 |
Transdermal nicotine use in postmenopausal women: does the treatment efficacy differ in women using and not using hormone replacement therapy?
Topics: Administration, Cutaneous; Adult; Aged; Counseling; Depression; Double-Blind Method; Female; Ganglionic Stimulants; Hormone Replacement Therapy; Humans; Middle Aged; Motor Skills Disorders; Nicotine; Placebos; Postmenopause; Reaction Time; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2004 |
Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial.
Topics: Administration, Cutaneous; Adult; Affect; Analysis of Variance; Antidepressive Agents; Cognition; Cross-Over Studies; Depression; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Nicotine; Nicotinic Agonists; Psychiatric Status Rating Scales; Saliva; Severity of Illness Index; Time Factors; Treatment Outcome | 2006 |
Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia.
Topics: Acute Disease; Adult; Cotinine; Demography; Depression; Female; Humans; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Prevalence; Psychotic Disorders; Receptors, Nicotinic; Recurrence; Schizophrenia; Severity of Illness Index; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers.
Topics: Adolescent; Adult; Aged; Clonidine; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Placebos; Risk Factors; Sex Factors; Smoking; Smoking Cessation; Substance-Related Disorders | 1993 |
Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments.
Topics: Administration, Cutaneous; Adult; Aged; Body Weight; Carbon Monoxide; Combined Modality Therapy; Cotinine; Counseling; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Placebos; Psychotherapy, Group; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome | 1994 |
Interactive effects of depression symptoms, nicotine dependence, and weight change on late smoking relapse.
Topics: Algorithms; Behavior Therapy; Body Weight; Chewing Gum; Depression; Follow-Up Studies; Humans; Nicotine; Recurrence; Risk Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Survival Analysis; Treatment Outcome | 1996 |
A comparison of sustained-release bupropion and placebo for smoking cessation.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action Preparations; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Weight Gain | 1997 |
Effects of monetary contingencies on smoking relapse: influences of trait depression, personality, and habitual nicotine intake.
Topics: Depression; Humans; Male; Nicotine; Personality; Recurrence; Reward; Smoking; Smoking Cessation; Smoking Prevention | 1999 |
Nicotine patch and paroxetine for smoking cessation.
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Paroxetine; Patient Compliance; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2000 |
Correlation between the experimental data from animal studies and therapetical effects of antidepressant drugs.
Topics: Animals; Antidepressive Agents; Depression; Electroencephalography; Female; Humans; Male; Nicotine; Norepinephrine; Physostigmine; Placebos; Rabbits; Reserpine; Tetrabenazine; Tremorine | 1971 |
131 other study(ies) available for nicotine and Depression
| Article | Year |
|---|---|
Discovery and Development of 3-(6-Chloropyridine-3-yloxymethyl)-2-azabicyclo[3.1.0]hexane Hydrochloride (SUVN-911): A Novel, Potent, Selective, and Orally Active Neuronal Nicotinic Acetylcholine α4β2 Receptor Antagonist for the Treatment of Depression.
Topics: Administration, Oral; Animals; Antidepressive Agents; Bridged Bicyclo Compounds; Depression; Halogenation; Humans; Male; Nicotinic Antagonists; Pyridines; Rats; Rats, Wistar; Receptors, Nicotinic | 2020 |
Nicotine preference and affective behavior of Cd81 knockout mice.
Topics: Animals; Anxiety; Behavior, Animal; Depression; Female; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Substance Withdrawal Syndrome | 2021 |
Repetitive Mild Traumatic Brain Injury in an Awake, Unanesthetized Mouse Model of Perinatal Nicotine Exposure Produces Transient Novelty-Seeking and Depression-Like Behaviors.
Topics: Animals; Brain Concussion; Depression; Disease Models, Animal; Exploratory Behavior; Female; Humans; Mice; Nicotine; Pregnancy; Wakefulness | 2022 |
Attenuation of nicotine-induced rewarding and antidepressant-like effects in male and female mice lacking regulator of G-protein signaling 2.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Conditioning, Psychological; Depression; Elevated Plus Maze Test; Female; Locomotion; Male; Mice; Nicotine; Reward; RGS Proteins | 2022 |
Discrimination and insomnia: Examining depressive symptoms and nicotine withdrawal through a serial mediation model in a sample of smokers.
Topics: Cross-Sectional Studies; Depression; Female; Humans; Male; Nicotine; Sleep Initiation and Maintenance Disorders; Smokers; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2023 |
Vaporized Nicotine (E-Cigarette) and Tobacco Smoking Among People With HIV: Use Patterns and Associations With Depression and Panic Symptoms.
Topics: Depression; Electronic Nicotine Delivery Systems; HIV Infections; Humans; Nicotine; Tobacco Smoking | 2023 |
The Mental Health of Poles during the COVID-19 Pandemic.
Topics: Adult; Anxiety; COVID-19; Cross-Sectional Studies; Depression; Female; Humans; Male; Mental Health; Nicotine; Pandemics; Prospective Studies; SARS-CoV-2; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders | 2023 |
Omega-3 fatty acids prevent nicotine withdrawal-induced exacerbation of anxiety and depression by affecting oxidative stress balance, inflammatory response, BDNF and serotonin metabolism in rats.
Topics: Animals; Anxiety; Brain-Derived Neurotrophic Factor; Depression; Fatty Acids, Omega-3; Male; Nicotine; Oxidative Stress; Rats; Serotonin; Substance Withdrawal Syndrome | 2023 |
Symptoms of Depression and Anxiety and Subsequent Use of Nicotine and THC in Electronic Cigarettes.
Topics: Adolescent; Adult; Anxiety; Depression; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Surveys and Questionnaires; Tobacco Products; Young Adult | 2023 |
Differences in biobehavioral measures of cigarette smoking by depression symptomology.
Topics: Cigarette Smoking; Depression; Humans; Nicotiana; Nicotine; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Disorder | 2023 |
Liver tryptophan 2,3-dioxygenase: a determinant of anxiety-like behaviour - studies with chronic nicotine administration in rats.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Depression; Dioxygenases; Female; Liver; Male; Mice; Nicotine; Rats; Serotonin; Tryptophan; Tryptophan Oxygenase | 2023 |
Depressive symptoms predict trajectories of electronic delivery nicotine systems, cigarette, and cannabis use across 4.5 years among college students.
Topics: Cannabis; Depression; Electronic Nicotine Delivery Systems; Humans; Nicotine; Students; Tobacco Products | 2023 |
Neurobehavioral effects of selected tobacco constituents in rodents following subchronic administration.
Topics: Alkaloids; Animals; Antidepressive Agents; Behavior, Animal; Coumaric Acids; Depression; Male; Memory; Mice, Inbred BALB C; Mice, Inbred C57BL; Nicotiana; Nicotine; Nootropic Agents; Pyridines; Rats, Long-Evans | 2019 |
Potential Moderating Effects of Psychiatric Diagnosis and Symptom Severity on Subjective and Behavioral Responses to Reduced Nicotine Content Cigarettes.
Topics: Anxiety; Depression; Humans; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Products | 2019 |
Adolescent nicotine induces depressive and anxiogenic effects through ERK 1-2 and Akt-GSK-3 pathways and neuronal dysregulation in the nucleus accumbens.
Topics: Adolescent; Animals; Anxiety; Biomarkers; Depression; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3; Humans; Male; Nicotine; Nucleus Accumbens; Phenotype; Rats, Sprague-Dawley; Signal Transduction; Tobacco Use Disorder | 2021 |
The role of pituitary adenylyl cyclase activating polypeptide in affective signs of nicotine withdrawal.
Topics: Animals; Anxiety; Conditioning, Psychological; Depression; Female; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Pituitary Adenylate Cyclase-Activating Polypeptide; Sex Factors; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2020 |
Nicotine Rescues Depressive-like Behaviors via α7-type Nicotinic Acetylcholine Receptor Activation in CaMKIV Null Mice.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Behavior, Animal; Benzamides; Benzylidene Compounds; Brain-Derived Neurotrophic Factor; Bridged Bicyclo Compounds; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Cyclic AMP Response Element-Binding Protein; Dentate Gyrus; Depression; Extracellular Signal-Regulated MAP Kinases; Mice, Knockout; Models, Biological; Neurogenesis; Nicotine; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridines | 2020 |
The reinforcement threshold and elasticity of demand for nicotine in an adolescent rat model of depression.
Topics: Animals; Depression; Disease Models, Animal; Elasticity; Humans; Nicotine; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Smokers; Smoking; Tobacco Use Disorder | 2021 |
Depression and Nicotine Withdrawal Associations with Combustible and Electronic Cigarette Use.
Topics: Adult; Cigarette Smoking; Cross-Sectional Studies; Depression; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Substance Withdrawal Syndrome; Vaping | 2020 |
Kynurenine 3-monooxygenase deficiency induces depression-like behavior via enhanced antagonism of α7 nicotinic acetylcholine receptors by kynurenic acid.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Behavior, Animal; Depression; Disease Models, Animal; Kynurenic Acid; Kynurenine 3-Monooxygenase; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Prefrontal Cortex | 2021 |
The Link Between Depressive Symptoms and Vaping Nicotine in U.S. Adolescents, 2017-2019.
Topics: Adolescent; Depression; Electronic Nicotine Delivery Systems; Humans; Nicotine; Tobacco Products; Vaping | 2022 |
Paternal nicotine exposure defines different behavior in subsequent generation via hyper-methylation of mmu-miR-15b.
Topics: Animals; Behavior, Animal; Cell Line; CpG Islands; Depression; DNA Methylation; Female; Gene Expression Profiling; Gene Order; Genetic Vectors; High-Throughput Nucleotide Sequencing; Humans; Male; Mice; MicroRNAs; Nicotine; Paternal Exposure; Phenotype; Pregnancy; Prenatal Exposure Delayed Effects; RNA, Messenger; Signal Transduction; Smoking; Spermatozoa; Transcriptome; Wnt4 Protein | 2017 |
Alpha-asarone attenuates depression-like behavior in nicotine-withdrawn mice: Evidence for the modulation of hippocampal pCREB levels during nicotine-withdrawal.
Topics: Allylbenzene Derivatives; Animals; Anisoles; Behavior, Animal; Body Weight; Brain-Derived Neurotrophic Factor; Cyclic AMP Response Element-Binding Protein; Depression; Drinking; Hippocampus; Locomotion; Male; Mice; Mice, Inbred C57BL; Nicotine; Phosphoproteins; Substance Withdrawal Syndrome | 2018 |
Nicotine alleviates chronic stress-induced anxiety and depressive-like behavior and hippocampal neuropathology via regulating autophagy signaling.
Topics: Animals; Anxiety; Autophagy; Chronic Disease; Depression; Dose-Response Relationship, Drug; Hippocampus; Male; Mice; Mice, Inbred C57BL; Nicotine; PC12 Cells; Rats; Signal Transduction; Stress, Psychological | 2018 |
Impacts of cannabinoid receptor ligands on nicotine- and chronic mild stress-induced cognitive and depression-like effects in mice.
Topics: Animals; Antidepressive Agents; Cannabinoid Receptor Modulators; Cognition; Depression; Disease Models, Animal; Male; Memory; Memory Disorders; Mice; Nicotine; Nicotinic Agonists; Nootropic Agents; Receptors, Cannabinoid; Stress, Psychological | 2018 |
Maternal nicotine exposure has severe cross-generational effects on offspring behavior.
Topics: Animals; Behavior, Animal; Depression; Depressive Disorder; Female; Glycogen Synthase Kinase 3; Male; Maternal Behavior; Maternal Inheritance; Mice; Mice, Inbred C57BL; Motor Activity; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects | 2018 |
A retrospective analysis of the association between providing nicotine replacement therapy at admission and motivation to quit and nicotine withdrawal symptoms during an inpatient psychiatric hospitalization.
Topics: Adult; Anger; Anxiety; Attention; Craving; Depression; Female; Hospitalization; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Retrospective Studies; Sleep Initiation and Maintenance Disorders; Smoking Cessation; Substance Withdrawal Syndrome | 2018 |
Regulator of G protein signaling 2 differentially regulates nicotine-induced anxiolytic- and antidepressant-like effects in mice.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Behavior, Animal; Depression; Depressive Disorder; Maze Learning; Mice, Knockout; Nicotine; RGS Proteins | 2018 |
Adolescent Nicotine Exposure Induces Dysregulation of Mesocorticolimbic Activity States and Depressive and Anxiety-like Prefrontal Cortical Molecular Phenotypes Persisting into Adulthood.
Topics: Animals; Anxiety; Behavior, Animal; Brain; Depression; Male; Nicotine; Nicotinic Agonists; Phenotype; Rats; Rats, Sprague-Dawley; Time | 2019 |
Electronic cigarette use is associated with depressive symptoms among smokers and former smokers: Cross-sectional and longitudinal findings from the Constances cohort.
Topics: Adolescent; Adult; Aged; Cross-Sectional Studies; Depression; Dose-Response Relationship, Drug; Ex-Smokers; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Smokers; Vaping; Young Adult | 2019 |
It is time to investigate integrative approaches to enhance treatment outcomes for depression?
Topics: Adult; Aged; Alcohol Drinking; Depression; Depressive Disorder; Diet; Dietary Supplements; Exercise; Female; Humans; Life Style; Male; Meditation; Mental Health Services; Middle Aged; Nicotine; Nutritional Status; Sleep; Spirituality; Sunlight; Treatment Outcome; Vitamins | 2019 |
Examining sex differences in pleiotropic effects for depression and smoking using polygenic and gene-region aggregation techniques.
Topics: Adult; Comorbidity; Depression; Depressive Disorder; Female; Genetic Pleiotropy; Humans; Male; Multifactorial Inheritance; Nerve Tissue Proteins; Nicotine; Receptors, Mineralocorticoid; Receptors, Nicotinic; Sex Factors; Smoking; Tacrolimus Binding Proteins; Tobacco Use Disorder | 2019 |
Propensity for social interaction predicts nicotine-reinforced behaviors in outbred rats.
Topics: Animals; Depression; Female; Male; Nicotine; Phenotype; Propensity Score; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Sex Characteristics; Social Behavior; Substance-Related Disorders | 2014 |
Anhedonia in obsessive-compulsive disorder: beyond comorbid depression.
Topics: Adolescent; Adult; Anhedonia; Comorbidity; Depression; Female; Humans; Male; Middle Aged; Nicotine; Obsessive-Compulsive Disorder; Pleasure; Prevalence; Reward; Smoking; Substance-Related Disorders; Surveys and Questionnaires; Young Adult | 2014 |
The effects of lobeline on nicotine withdrawal-induced depression-like behavior in mice.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cotinine; Cyclic AMP Response Element-Binding Protein; Depression; Disease Models, Animal; Hippocampus; Lobeline; Male; Mice, Inbred C57BL; Motor Activity; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Norepinephrine; Prefrontal Cortex; Receptors, Nicotinic; Substance Withdrawal Syndrome; Swimming; Tobacco Use Disorder | 2014 |
Influence of calcium channel antagonists on nonsomatic signs of nicotine and D-amphetamine withdrawal in mice.
Topics: Animals; Anxiety; Calcium; Calcium Channel Blockers; Calcium Channels; Depression; Dextroamphetamine; Memory; Mice; Nicotine; Nociception; Substance Withdrawal Syndrome | 2014 |
Family Beliefs and Behaviors About Smoking and Young Children's Secondhand Smoke Exposure.
Topics: Attitude to Health; Biomarkers; Caregivers; Child; Child, Preschool; Cotinine; Depression; Family; Female; Health Behavior; Humans; Infant; Male; Nicotine; Risk Factors; Self Efficacy; Stress, Psychological; Tobacco Smoke Pollution | 2015 |
Chronic agmatine treatment prevents behavioral manifestations of nicotine withdrawal in mice.
Topics: Agmatine; Animals; Anxiety; Behavior, Animal; Brain; Depression; Infusions, Intraventricular; Male; Mice; Nicotine; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
The effects of nicotine dependence and acute abstinence on the processing of drug and non-drug rewards.
Topics: Carbon Monoxide; Choice Behavior; Craving; Cross-Over Studies; Depression; Female; Humans; Male; Motivation; Nicotine; Pleasure; Psychomotor Performance; Reading; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2015 |
Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.
Topics: Administration, Cutaneous; Analysis of Variance; Anxiety; Biomarkers; Cotinine; Craving; Depression; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Protective effects of forced exercise against nicotine-induced anxiety, depression and cognition impairment in rat.
Topics: Animals; Anxiety; Behavior, Animal; Brain; Cognition Disorders; Depression; Hindlimb Suspension; Male; Maze Learning; Nicotine; Physical Conditioning, Animal; Rats; Substance Withdrawal Syndrome | 2016 |
In vivo modulation of the behavioral effects of nicotine by the coumarins xanthotoxin, bergapten, and umbelliferone.
Topics: 5-Methoxypsoralen; Animals; Antidepressive Agents; Avoidance Learning; Behavior, Animal; Coumarins; Cytochrome P-450 CYP2A6; Depression; Locomotion; Male; Memory; Methoxsalen; Mice; Nicotine; Nicotinic Agonists; Nootropic Agents; Swimming; Umbelliferones | 2016 |
Putative Epigenetic Involvement of the Endocannabinoid System in Anxiety- and Depression-Related Behaviors Caused by Nicotine as a Stressor.
Topics: Acetylation; Animals; Anxiety; Behavior, Animal; Depression; Drug Interactions; Endocannabinoids; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histones; Immobilization; Male; Maze Learning; Mice; Mice, Inbred ICR; Nicotine; Receptor, Cannabinoid, CB1; Stress, Psychological | 2016 |
Impact of self-reported lifetime depression or anxiety on effectiveness of mass distribution of nicotine patches.
Topics: Adult; Aged; Anxiety; Depression; Female; Humans; Male; Middle Aged; Nicotine; Randomized Controlled Trials as Topic; Self Report; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2016 |
Long-term effects of chronic nicotine on emotional and cognitive behaviors and hippocampus cell morphology in mice: comparisons of adult and adolescent nicotine exposure.
Topics: Animals; Cognition; Conditioning, Classical; Depression; Emotions; Hippocampus; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Pyramidal Cells | 2016 |
Selective CRF2 receptor agonists ameliorate the anxiety- and depression-like state developed during chronic nicotine treatment and consequent acute withdrawal in mice.
Topics: Animals; Anxiety; Corticosterone; Depression; Disease Models, Animal; Drug Evaluation, Preclinical; Hypothalamo-Hypophyseal System; Infusions, Intraventricular; Male; Mice; Motor Activity; Nicotine; Nicotinic Agonists; Pituitary-Adrenal System; Psychotropic Drugs; Receptors, Corticotropin-Releasing Hormone; Substance Withdrawal Syndrome; Tobacco Use Disorder; Urocortins | 2016 |
Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors.
Topics: Amidohydrolases; Animals; Benzamides; Carbamates; Depression; Habenula; Male; Nicotine; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Self Administration; Substance Withdrawal Syndrome | 2017 |
Negative affect subtypes and craving differentially predict long-term cessation success among smokers achieving initial abstinence.
Topics: Adult; Affective Symptoms; Anger; Anxiety; Craving; Depression; Female; Humans; Logistic Models; Male; Motivation; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Recurrence; Risk; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Smoking; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2017 |
Antidepressant-like effects of nicotine and transcranial magnetic stimulation in the olfactory bulbectomy rat model of depression.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Drug Administration Schedule; Exploratory Behavior; Injections, Intraperitoneal; Male; Motor Activity; Nicotine; Olfactory Bulb; Psychology, Comparative; Rats; Rats, Long-Evans; Rats, Wistar; Self Administration; Species Specificity; Swimming; Transcranial Magnetic Stimulation | 2008 |
Correspondence of Interactive Voice Response (IVR) reports of nicotine withdrawal, craving, and negative mood with questionnaire ratings.
Topics: Adult; Comorbidity; Depression; Female; Humans; Irritable Mood; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Self Disclosure; Self-Assessment; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2008 |
What's new in Nicotine & Tobacco Research?
Topics: Depression; Flavoring Agents; Humans; Nicotine; Primary Prevention; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Industry; United States | 2008 |
Varenicline: depression and suicide. Nicotine is a safer option.
Topics: Benzazepines; Depression; Humans; Nicotine; Quinoxalines; Smoking Cessation; Suicide | 2008 |
Chronic effect of nicotine on serotonin transporter mRNA in the raphe nucleus of rats: reversal by co-administration of bupropion.
Topics: Animals; Bupropion; Depression; Dose-Response Relationship, Drug; Drug Administration Routes; Gene Expression; Male; Nicotine; Raphe Nuclei; Rats; Rats, Wistar; RNA, Messenger; Serotonin Plasma Membrane Transport Proteins; Smoking Cessation; Substance Withdrawal Syndrome | 2008 |
Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism.
Topics: Alcoholism; Alkaloids; Analysis of Variance; Animals; Antidepressive Agents; Azocines; Depression; Disease Models, Animal; Drug Administration Schedule; Male; Nicotine; Protein Binding; Quinolizines; Rats; Rats, Inbred Strains; Receptors, Nicotinic; Swimming; Tritium | 2009 |
Mood and smoking in schizophrenia.
Topics: Adult; Affect; Anxiety; Depression; Female; Humans; Male; Middle Aged; Nicotine; Schizophrenic Psychology; Smoking | 2008 |
Nicotine (NC)-induced "depressive" behavioral symptoms and effects of antidepressants including cannabinoids (CBs).
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cannabinoids; Data Interpretation, Statistical; Depression; Disease Models, Animal; Male; Mice; Mice, Inbred ICR; Nicotine; Restraint, Physical; Stress, Psychological; Swimming; Time Factors | 2008 |
Nicotine exposure during adolescence induces a depression-like state in adulthood.
Topics: Aging; Animals; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Cholinergic Agents; Depression; Emotions; Fluoxetine; Food Preferences; Male; Motor Activity; Nicotine; Rats; Rats, Sprague-Dawley; Reward; Stress, Psychological; Weight Gain | 2009 |
Of common nicotine withdrawal symptoms, depression and increased appetite are covered, with other contributions concerning endocrine, cardiovascular and respiratory changes. Preface.
Topics: Appetite; Depression; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2009 |
Serotonin transporter genotype and depressive symptoms moderate effects of nicotine on spatial working memory.
Topics: Adolescent; Adult; Depression; Double-Blind Method; Female; Genotype; Hippocampus; Humans; Male; Memory; Middle Aged; Nicotine; Serotonin Plasma Membrane Transport Proteins; Spatial Behavior | 2009 |
Effects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Depression; Diagnosis, Computer-Assisted; Disease Models, Animal; Drug Administration Schedule; Exploratory Behavior; Female; Hippocampus; Immobility Response, Tonic; Motor Activity; Nicotine; Rats; Rats, Inbred WKY; Rats, Wistar; Stereotaxic Techniques; Swimming; Time Factors | 2010 |
Smoking behaviour is associated with expression and phosphorylation of CREB in human buffy coat.
Topics: Adult; Aging; Alcoholism; Anxiety; Cyclic AMP Response Element-Binding Protein; Depression; Female; Gene Expression; Humans; Male; Nicotine; Phosphorylation; Sex Characteristics; Smoking; Tobacco Use Disorder | 2010 |
Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal.
Topics: Animals; Antidepressive Agents, Tricyclic; Depression; Imipramine; Male; Motor Activity; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Substance Withdrawal Syndrome; Swimming; Time Factors; Treatment Outcome | 2010 |
Possible testable correlations between passive smoking and bipolar/cyclothymic disorder, depression and ADD/ADHD.
Topics: Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Depression; Humans; Models, Psychological; Nicotine; Reward; Tobacco Smoke Pollution | 2010 |
Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.
Topics: Animals; Anxiety; Azetidines; Behavior, Animal; Benzazepines; Chimera; Depression; Drug Partial Agonism; Male; Mice; Mood Disorders; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Varenicline | 2010 |
Withdrawal from chronic exposure to amphetamine, but not nicotine, leads to an immediate and enduring deficit in motivated behavior without affecting social interaction in rats.
Topics: Amphetamine; Animals; Body Weight; Central Nervous System Stimulants; Conditioning, Operant; Depression; Drinking; Eating; Interpersonal Relations; Male; Motivation; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Reinforcement Schedule; Reward; Substance Withdrawal Syndrome; Sucrose; Weight Gain | 2010 |
Behavioral sensitization to nicotine in female and male rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Body Weight; Depression; Female; Male; Motor Activity; Nicotine; Rats; Rats, Wistar; Sex Factors | 2010 |
Nicotine dependence and depression among women smokers on methadone maintenance.
Topics: Adult; Cross-Sectional Studies; Depression; Female; Humans; Linear Models; Methadone; Middle Aged; Nicotine; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; Smoking; Smoking Cessation; Statistics, Nonparametric | 2010 |
Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertraline.
Topics: Anhedonia; Animals; Antidepressive Agents; Behavior, Animal; Cognition Disorders; Depression; Disease Models, Animal; Drug Therapy, Combination; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Sertraline; Stress, Psychological; Sucrose | 2011 |
Both GABA(B) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats.
Topics: Animals; Benzoates; Depression; Drug Synergism; GABA-B Receptor Agonists; GABA-B Receptor Antagonists; gamma-Aminobutyric Acid; Male; Nicotine; Phosphinic Acids; Pyrimidines; Rats; Rats, Wistar; Receptors, GABA-B; Reward; Self Stimulation; Substance Withdrawal Syndrome | 2011 |
Depression-related anhedonic behaviors caused by immobilization stress: a comparison with nicotine-induced depression-like behavioral alterations and effects of nicotine and/or "antidepressant" drugs.
Topics: Affective Symptoms; Animals; Antidepressive Agents; Cannabinoids; Depression; Hindlimb Suspension; Male; Mice; Mice, Inbred ICR; Nicotine; Restraint, Physical; Stress, Physiological | 2011 |
L-DOPA attenuates nicotine withdrawal-induced behaviors in rats.
Topics: Animals; Behavior, Animal; Depression; Dopamine Agents; Levodopa; Male; Motor Activity; Nicotine; Rats; Rats, Sprague-Dawley; Smoking Cessation; Substance Withdrawal Syndrome | 2011 |
Maternal characteristics predicting young girls' disruptive behavior.
Topics: Attention Deficit and Disruptive Behavior Disorders; Child; Depression; Female; Humans; Longitudinal Studies; Mother-Child Relations; Mothers; Multivariate Analysis; Nicotine; Parenting; Pregnancy; Prenatal Exposure Delayed Effects | 2011 |
Exposure to nicotine and ethanol in adolescent mice: effects on depressive-like behavior during exposure and withdrawal.
Topics: Animals; Body Weight; Choice Behavior; Depression; Disease Models, Animal; Drug Interactions; Ethanol; Female; Immobility Response, Tonic; Male; Mice; Mice, Inbred C57BL; Nicotine; Physical Endurance; Sex Characteristics; Substance Withdrawal Syndrome; Sucrose; Time Factors | 2011 |
Nicotine withdrawal-induced negative affect is a function of nicotine dependence and not liability to depression or anxiety.
Topics: Adult; Anxiety; Depression; Female; Humans; Male; Nicotine; Regression Analysis; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder; Twins; Young Adult | 2011 |
Effect of magnesium chloride on psychomotor activity, emotional status, and acute behavioural responses to clonidine, d-amphetamine, arecoline, nicotine, apomorphine, and L-5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Anxiety; Apomorphine; Arecoline; Clonidine; Depression; Diet; Dietary Supplements; Emotions; Magnesium; Magnesium Chloride; Magnesium Deficiency; Male; Neurotransmitter Agents; Nicotine; Psychomotor Performance; Rats; Rats, Wistar; Stereotyped Behavior; Vitamin B 6 | 2011 |
Association between DRD2/ANKK1 Taq1A genotypes, depression and smoking cessation with nicotine replacement therapy.
Topics: Adult; Depression; Female; Genetic Association Studies; Genotype; Humans; Logistic Models; Male; Middle Aged; Nicotine; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases; Receptors, Dopamine D2; Smoking; Smoking Cessation; Surveys and Questionnaires; Taq Polymerase; Tobacco Use Disorder; Young Adult | 2011 |
Maternal prenatal depressive symptoms, nicotine addiction, and smoking-related knowledge, attitudes, beliefs, and behaviors.
Topics: Adolescent; Adult; Behavior, Addictive; Black or African American; Depression; Female; Health Knowledge, Attitudes, Practice; Humans; Interviews as Topic; Nicotine; North Carolina; Pregnancy; Pregnancy Outcome; Prenatal Care; Smoking; Social Environment; Surveys and Questionnaires; Tobacco Use Disorder; Young Adult | 2012 |
Differential effects of TRPV1 receptor ligands against nicotine-induced depression-like behaviors.
Topics: Animals; Antidepressive Agents; Arachidonic Acids; Capsaicin; Depression; Dopamine; Endocannabinoids; Hindlimb Suspension; Ligands; Male; Mice; Mice, Inbred ICR; Nicotine; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Stress, Psychological; Swimming; TRPV Cation Channels | 2011 |
Predictors of short-term success in smoking cessation in relation to attendance at a smoking cessation program.
Topics: Adaptation, Psychological; Adult; Carbon Monoxide; Counseling; Depression; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Young Adult | 2011 |
Nicotine restores monoamine neurotransmitter changes in the cortex and hippocampus of reserpinized rats as a model of depression.
Topics: Animals; Antidepressive Agents; Cerebral Cortex; Depression; Disease Models, Animal; Dopamine; Hippocampus; Male; Neurotransmitter Agents; Nicotine; Norepinephrine; Rats; Reserpine; Serotonin | 2011 |
Anger, hostility, and aggression as predictors of persistent smoking during pregnancy.
Topics: Adolescent; Adult; Aggression; Anger; Cotinine; Depression; Female; Hostility; Humans; Infant, Newborn; Meconium; Nicotine; Pregnancy; Prospective Studies; Saliva; Smoking; Stress, Psychological; Young Adult | 2011 |
Suicidal behavior and depression in smoking cessation treatments.
Topics: Adult; Benzazepines; Bupropion; Depression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicide; Varenicline | 2011 |
Predictors of risk for smoking relapse in men and women: a prospective examination.
Topics: Adult; Anger; Anxiety; Depression; Female; Follow-Up Studies; Ganglionic Stimulants; Humans; Male; Motivation; Nicotine; Prospective Studies; Recurrence; Risk Factors; Sex Factors; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2012 |
Explaining the stress-inducing effects of nicotine to cigarette smokers.
Topics: Adolescent; Adult; Affect; Cohort Studies; Depression; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Models, Psychological; Nicotine; Patient Education as Topic; Smoking; Smoking Cessation; Stress, Psychological; Tobacco Use Disorder; Young Adult | 2012 |
Mice lacking the β4 subunit of the nicotinic acetylcholine receptor show memory deficits, altered anxiety- and depression-like behavior, and diminished nicotine-induced analgesia.
Topics: Amygdala; Analgesics; Animals; Anxiety; Behavior, Animal; Cognition; Conditioning, Psychological; Cues; Depression; Fear; Female; Learning; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Nerve Tissue Proteins; Nicotine; Receptors, Nicotinic | 2012 |
Serotonin involvement in Rhodiola rosea attenuation of nicotine withdrawal signs in rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain; Depression; Male; Nicotine; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Rhodiola; Serotonin; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2012 |
Prenatal cocaine and/or nicotine exposure produces depression and anxiety in aging rats.
Topics: Aging; Animals; Anxiety; Cocaine; Depression; Female; Male; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Sex Characteristics | 2003 |
Nicotine withdrawal and depressive symptomatology during short-term smoking abstinence: a comparison of postmenopausal women using and not using hormone replacement therapy.
Topics: Adult; Aged; Counseling; Depression; Female; Hormone Replacement Therapy; Humans; Middle Aged; Nicotine; Postmenopause; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 2003 |
C-reactive protein and depressed mood in a sub-group of smokers during nicotine abstinence.
Topics: Adolescent; Blood Pressure; C-Reactive Protein; Depression; Female; Heart Rate; Humans; Interleukin-1; Interleukin-6; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
Nicotine withdrawal induces subsensitivity of hypothalamic-pituitary-adrenal axis to stress in rats: implications for precipitation of depression during smoking cessation.
Topics: Adaptation, Physiological; Adrenal Cortex Function Tests; Animals; Corticosterone; Depression; Dexamethasone; Disease Models, Animal; Glucocorticoids; Hippocampus; Hypothalamo-Hypophyseal System; Male; Nicotine; Nicotinic Agonists; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Rats; Rats, Wistar; Receptors, Glucocorticoid; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome | 2004 |
Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with fluoxetine [correction of flouxetine].
Topics: Animals; Antidepressive Agents; Depression; Drug Administration Schedule; Drug Interactions; Drug Synergism; Fluoxetine; Immobilization; Male; Motor Activity; Nicotine; Rats; Rats, Wistar; Swimming | 2004 |
Effects of quitting smoking on EEG activation and attention last for more than 31 days and are more severe with stress, dependence, DRD2 A1 allele, and depressive traits.
Topics: Adolescent; Adult; Attention; Cognition; Depression; Electroencephalography; Female; Ganglionic Stimulants; Heart Rate; Humans; Nicotine; Polymorphism, Genetic; Receptors, Dopamine D2; Smoking Cessation; Stress, Psychological; Time Factors; Tobacco Use Disorder | 2004 |
Long-term neurobehavioral effects of alcohol or nicotine exposure in adolescent animal models.
Topics: Administration, Cutaneous; Adolescent; Age Factors; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Central Nervous System Depressants; Depression; Dose-Response Relationship, Drug; Electroencephalography; Ethanol; Exploratory Behavior; Humans; Models, Animal; Nicotine; Nicotinic Agonists; Rats; Reaction Time; Time; Time Factors | 2004 |
Nicotine dependence, depression, and gender: characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain.
Topics: Adult; Aged; Aged, 80 and over; Anxiety; Depression; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Phenotype; Sex Factors; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2005 |
Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior.
Topics: Age Factors; Animals; Antibodies; Anxiety; Corticotropin-Releasing Hormone; Depression; Immunohistochemistry; Male; Maze Learning; Neuropeptide Y; Neurosecretory Systems; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Swimming | 2005 |
Nicotine and cognitive efficiency in alcoholics and illicit stimulant abusers: implications of smoking cessation for substance users in treatment.
Topics: Administration, Cutaneous; Adult; Alcoholism; Cognition; Cognition Disorders; Depression; Female; Humans; Illicit Drugs; Male; Mass Screening; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Severity of Illness Index; Smoking; Smoking Cessation; Substance-Related Disorders; Visual Perception | 2006 |
Transactions among adolescent trait and state emotion and diurnal and momentary cortisol activity in naturalistic settings.
Topics: Adolescent; Adult; Affect; Anger; Anxiety; Circadian Rhythm; Depression; Emotions; Female; Humans; Hydrocortisone; Male; Nicotine; Puberty; Saliva; Smoking | 2006 |
The influence of tobacco smoke and nicotine on antidepressant and memory-improving effects of venlafaxine.
Topics: Animals; Antidepressive Agents, Second-Generation; Atmosphere Exposure Chambers; Behavior, Animal; Cyclohexanols; Depression; Female; Maze Learning; Memory; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Smoking; Swimming; Venlafaxine Hydrochloride | 2006 |
Long-term effects of nicotine on the forced swimming test in mice: an experimental model for the study of depression caused by smoke.
Topics: Animals; Blotting, Western; Depression; Male; Mice; Nicotine; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Smoke; Stress, Physiological; Substance Withdrawal Syndrome; Swimming | 2006 |
Chronic nicotine doses down-regulate PDE4 isoforms that are targets of antidepressants in adolescent female rats.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Analysis of Variance; Animals; Animals, Newborn; Brain; Chromosome Mapping; Cyclic Nucleotide Phosphodiesterases, Type 4; Depression; Disease Models, Animal; Down-Regulation; Drug Administration Schedule; Female; Humans; Nicotine; Nicotinic Agonists; Oligonucleotide Array Sequence Analysis; Protein Isoforms; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Distribution | 2007 |
Depression and Anxiety--SMi's second conference. 28-29 June 2006, London, UK.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Central Nervous System Agents; Depression; Drug Industry; Humans; Nicotine; Placebo Effect; Receptors, Nicotinic | 2006 |
Nicotine dependence and withdrawal symptoms among occasional smokers.
Topics: Adolescent; Adolescent Behavior; Analysis of Variance; Chi-Square Distribution; Cross-Sectional Studies; Depression; Female; Humans; Male; Nicotine; Psychology, Adolescent; Risk-Taking; Smoking Cessation; South Africa; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
Substance use and related problems: a study on the abuse of recreational and not recreational drugs in Northern Italy.
Topics: Accidents, Traffic; Adult; Alcoholism; Amphetamines; Anxiety; Crack Cocaine; Depression; Female; Hallucinogens; Heroin; Humans; Italy; Ketamine; Male; Marijuana Abuse; Nicotine; Opium; Sleep Wake Disorders; Substance-Related Disorders; Surveys and Questionnaires | 2006 |
Long-term changes in sleep and depressive symptoms of smokers in abstinence.
Topics: Adult; Cotinine; Depression; Female; Follow-Up Studies; Humans; Logistic Models; Longitudinal Studies; Male; Mexico; Middle Aged; Nicotine; Polysomnography; Sleep Initiation and Maintenance Disorders; Sleep, REM; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral symptoms: effects of anxiolytic and cannabinoid drugs.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Cannabinoid Receptor Agonists; Cannabinoids; Depression; Male; Mice; Mice, Inbred ICR; Motor Activity; Nicotine; Receptors, Cannabinoid; Time Factors | 2007 |
Association between depressive mood and cigarette smoking in a large Italian sample of smokers intending to quit: implications for treatment.
Topics: Adult; Affect; Cross-Sectional Studies; Depression; Female; Health Status Indicators; Humans; Italy; Male; Nicotine; Prevalence; Psychological Tests; Psychometrics; Risk Factors; Sickness Impact Profile; Smoking; Smoking Cessation | 2007 |
Emotional stimuli and context moderate effects of nicotine on specific but not global affects.
Topics: Adult; Affect; Anxiety; Attention; Depression; Emotions; Female; Humans; Male; Nicotine; Sex Characteristics | 2008 |
Physiological and psychological symptoms and predictors in early nicotine withdrawal.
Topics: Adult; Anxiety; Blood Pressure; Depression; Female; Heart Rate; Humans; Linear Models; Male; Nicotine; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
What's new in nicotine & tobacco research?
Topics: Advertising; Affect; Cardiovascular Diseases; Causality; Comorbidity; Depression; Humans; Nicotine; Research Design; Smoking; Smoking Cessation; Tobacco Industry; Tobacco Use Disorder | 2008 |
The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat.
Topics: Animals; Antidepressive Agents, Tricyclic; Conditioning, Operant; Depression; Desipramine; Food; Infusion Pumps, Implantable; Injections, Intravenous; Nicotine; Nicotinic Agonists; Rats; Reward; Self Administration; Self Stimulation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Immediate increases in plasma prolactin and neurophysin but not other hormones after electroconvulsive therapy.
Topics: Adult; Aged; Depression; Electroconvulsive Therapy; Estrogens; Female; Hormones; Humans; Middle Aged; Neurophysins; Nicotine; Prolactin; Psychiatric Status Rating Scales; Stimulation, Chemical; Time Factors | 1982 |
Psychiatric comorbidity of smoking and nicotine dependence.
Topics: Adolescent; Adolescent Behavior; Adult; Alcoholism; Anxiety; Chi-Square Distribution; Comorbidity; Depression; Female; Humans; Male; Michigan; Nicotine; Odds Ratio; Prevalence; Risk Factors; Sex Factors; Smoking; Substance-Related Disorders; Tobacco Use Disorder | 1995 |
Alexithymia and negative affect: relationship to cigarette smoking, nicotine dependence, and smoking cessation.
Topics: Adolescent; Adult; Affective Symptoms; Aged; Depression; Female; Humans; Male; Middle Aged; Nicotine; Personality Inventory; Smoking; Smoking Cessation; Substance-Related Disorders | 1994 |
Smoking cessation in young adults: age at initiation of cigarette smoking and other suspected influences.
Topics: Adolescent; Adult; Age Factors; Depression; Educational Status; Ethnicity; Female; Humans; Longitudinal Studies; Male; Michigan; Multivariate Analysis; Nicotine; Proportional Hazards Models; Risk Factors; Sampling Studies; Smoking Cessation; Social Behavior; Substance-Related Disorders | 1996 |
Nicotine dependence and depression among methadone maintenance patients.
Topics: Adult; Aged; Depression; Female; Humans; Logistic Models; Male; Methadone; Middle Aged; Nicotine; Odds Ratio; Opioid-Related Disorders; Smoking; Smoking Cessation; Substance Abuse Treatment Centers; Substance-Related Disorders; Treatment Outcome | 1996 |
Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene.
Topics: Adult; Depression; Female; Genetic Markers; Genotype; Humans; Linear Models; Male; Middle Aged; Nicotine; Receptors, Dopamine D2; Receptors, Dopamine D4; Self Medication; Smoking; Smoking Cessation | 1998 |
Nicotine dependence among adolescent smokers.
Topics: Adolescent; Cotinine; Cross-Sectional Studies; Depression; Female; Humans; Linear Models; Male; Nicotine; Prevalence; Psychological Tests; Saliva; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1998 |
Antidepressant effects of nicotine in an animal model of depression.
Topics: Alkaloids; Animals; Antidepressive Agents; Azocines; Binding Sites; Body Temperature; Bungarotoxins; Depression; Disease Models, Animal; Iodine Radioisotopes; Male; Motor Activity; Nicotine; Nicotinic Agonists; Quinolizines; Rats; Receptors, Nicotinic; Tritium | 1999 |
[Nicotine replacement therapy and smoking cessation: what choice for its status?].
Topics: Depression; Humans; Mental Disorders; Nicotine; Self Medication; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 1999 |
Depressive characteristics of FSL rats: involvement of central nicotinic receptors.
Topics: Alkaloids; Animals; Antidepressive Agents; Azocines; Depression; Male; Mecamylamine; Nicotine; Quinolizines; Rats; Receptors, Nicotinic | 2000 |
The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acoustic Stimulation; Animals; Body Temperature; Columbidae; Corticosterone; Depression; Discrimination Learning; Drug Interactions; Fluoxetine; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Lip; Male; Microdialysis; Neurons; Nicotine; Piperidines; Posture; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Sulfur Radioisotopes | 2000 |
Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Depression; Dose-Response Relationship, Drug; Imipramine; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Pyridines; Pyrrolidines; Rats; Rats, Sprague-Dawley | 2000 |
Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats.
Topics: Aminopyridines; Amphetamine; Amphetamine-Related Disorders; Animals; Body Weight; Brain; Depression; Disease Models, Animal; Drug Combinations; Electric Stimulation; Fluoxetine; Male; Mecamylamine; Neurons; Nicotine; Nicotinic Antagonists; Piperazines; Rats; Rats, Wistar; Reaction Time; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Substance Withdrawal Syndrome; Synaptic Transmission; Tobacco Use Disorder | 2001 |
Effects of nicotine on alcohol intake in a rat model of depression.
Topics: Alcohol Drinking; Animals; Depression; Disease Models, Animal; Male; Motor Activity; Nicotine; Rats; Rats, Long-Evans | 2002 |
The effect of alcohol and smoking on testosterone function and aggression in chronic alcoholics.
Topics: Adult; Affect; Aggression; Alcoholism; Anxiety; Depression; Ethanol; Hostility; Humans; Male; Nicotine; Smoking; Testosterone | 1977 |
Nicotine dependence in an urban population of young adults: prevalence and co-morbidity with depression, anxiety and other substance dependencies.
Topics: Adult; Anxiety Disorders; Black or African American; Depression; Education; Female; Humans; Male; Nicotine; Substance-Related Disorders; White People | 1990 |
Constant exposure to darkness produces supersensitivity to nicotine.
Topics: Animals; Body Temperature Regulation; Darkness; Depression; Hypothermia; Male; Nicotine; Rats; Rats, Inbred Strains | 1990 |
Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking.
Topics: Adult; Depression; Female; Humans; Male; Nicotine; Recurrence; Smoking; Substance Withdrawal Syndrome | 1989 |
Clonidine, depression, and smoking cessation.
Topics: Behavior Therapy; Clonidine; Depression; Humans; Nicotine; Smoking | 1988 |
Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
Topics: Adrenergic beta-Antagonists; Amphetamine; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Anticonvulsants; Arrhythmias, Cardiac; Barbiturates; Blood Pressure; Cardiovascular System; Chloroform; Depression; Dogs; Drug Synergism; Epinephrine; Female; Guinea Pigs; Heart Atria; Humans; In Vitro Techniques; Intestinal Absorption; Isoproterenol; Male; Mice; Muscle Contraction; Muscle, Smooth; Nicotine; Ouabain; Pentylenetetrazole; Propranolol; Rabbits; Rats; Strychnine; Sympatholytics | 1970 |
The toxicologic and pharmacologic properties of amantadine hydrochloride.
Topics: Abnormalities, Drug-Induced; Acetylcholine; Amantadine; Analgesia; Animals; Arrhythmias, Cardiac; Blood Chemical Analysis; Blood Pressure; Central Nervous System; Depression; Dextroamphetamine; Dogs; Drug Synergism; Electrocardiography; Female; Guinea Pigs; Haplorhini; Heart Rate; Histamine; Horses; Humans; Imipramine; Injections, Intraperitoneal; Injections, Intravenous; Male; Mice; Motor Activity; Nicotine; Norepinephrine; Phenethylamines; Rabbits; Rats; Reproduction; Tetrabenazine; Tritium | 1969 |